FDA publishes ICH Q9 Draft Document
Register now for ECA's GMP Newsletter
Since the end of last year, the ICH Q9 document on quality risk management has been in stage 2 of the ICH process for publishing ICH documents as a draft revision 1. Now, the draft document has also been published by the FDA on its website and is available for comments.
Under Draft revision of ICH Q9 Quality Risk Management Guideline published you could already read about the ICH Q9 draft document - as well as about the comments provided by an ECA Expert Group; see Comments on the new ICH Q9 Guideline Q9 (Quality Risk Management) published.
The FDA has now also published the draft document on its website as "Draft Guidance for Industry" dated 14 June 2022. Comments on the draft document can be submitted online or in writing to the FDA.
You can find the FDA information at Q9(R1) Quality Risk Management on the FDA website.
Related GMP News
25.06.2025Is Knowledge Management a Part of the Pharmaceutical Quality System?
11.06.2025Swissmedic differentiates GMP Scope for Manufacturing and Preparation for Administration
28.05.2025A View on the EU Critical Medicines Act to secure Pharma Supply Chains
20.05.2025Summary Data on Registration and Listing of Cosmetic Facilities and Products
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review